24 research outputs found
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia
Background: Dementia is one of the most common diseases in elderly people and hundreds of thousand new cases per year of Alzheimer’s disease (AD) are estimated. While the recent decade has seen significant advances in the development of novel biomarkers to identify dementias at their early stage, a great effort has been recently made to identify biomarkers able to improve differential diagnosis. However, only few potential candidates, mainly detectable in cerebrospinal fluid (CSF), have been described so far.
Methods: We searched for miRNAs regulating MAPT translation. We employed a capture technology able to find the miRNAs directly bound to the MAPT transcript in cell lines. Afterwards, we evaluated the levels of these miRNAs in plasma samples from FTD (n = 42) and AD patients (n = 33) and relative healthy controls (HCs) (n = 42) by using qRT-PCR.
Results: Firstly, we found all miRNAs that interact with the MAPT transcript. Ten miRNAs have been selected to verify their effect on Tau levels increasing or reducing miRNA levels by using cell transfections with plasmids expressing the miRNAs genes or LNA antagomiRs. Following the results obtained, miR-92a-3p, miR-320a and miR-320b were selected to analyse their levels in plasma samples of patients with FTD and AD respect to HCs. The analysis showed that the miR-92a-1-3p was under-expressed in both AD and FTD compared to HCs. Moreover, miR-320a was upregulated in FTD vs. AD patients, particularly in men when we stratified by sex. Respect to HC, the only difference is showed in men with AD who have reduced levels of this miRNA. Instead, miR-320b is up-regulated in both dementias, but only patients with FTD maintain this trend in both genders.
Conclusions: Our results seem to identify miR-92a-3p and miR-320a as possible good biomarkers to discriminate AD from HC, while miR-320b to discriminate FTD from HC, particularly in males. Combining three miRNAs improves the accuracy only in females, particularly for differential diagnosis (FTD vs. AD) and to distinguish FTD from H
SARS-CoV-2 infection predicts larger infarct volume in patients with acute ischemic stroke
Background and purpose: Acute ischemic stroke (AIS) is a fearful complication of Coronavirus Disease-2019 (COVID-19). Aims of this study were to compare clinical/radiological characteristics, endothelial and coagulation dysfunction between acute ischemic stroke (AIS) patients with and without COVID-19 and to investigate if and how the SARS-CoV-2 spike protein (SP) was implicated in triggering platelet activation. Methods: We enrolled AIS patients with COVID-19 within 12 h from onset and compared them with an age- and sex-matched cohort of AIS controls without COVID-19. Neuroimaging studies were performed within 24 h. Blood samples were collected in a subset of 10 patients. Results: Of 39 AIS patients, 22 had COVID-19 and 17 did not. Admission levels of Factor VIII and von Willebrand factor antigen were significantly higher in COVID-19 patients and positively correlated with the infarct volume. In multivariate linear regression analyses, COVID-19 was an independent predictor of infarct volume (B 20.318, Beta 0.576, 95%CI 6.077-34.559; p = 0.011). SP was found in serum of 2 of the 10 examined COVID-19 patients. Platelets from healthy donors showed a similar degree of procoagulant activation induced by COVID-19 and non-COVID-19 patients' sera. The anti-SP and anti-FcγRIIA blocking antibodies had no effect in modulating platelet activity in both groups. Conclusions: SARS-CoV-2 infection seems to play a major role in endothelium activation and infarct volume extension during AIS
Heme Oxygenase-1 and Brain Oxysterols Metabolism Are Linked to Egr-1 Expression in Aged Mice Cortex, but Not in Hippocampus
Throughout life, stress stimuli act upon the brain leading to morphological and functional changes in advanced age, when it is likely to develop neurodegenerative disorders. There is an increasing need to unveil the molecular mechanisms underlying aging, in a world where populations are getting older. Egr-1 (early growth response 1), a transcriptional factor involved in cell survival, proliferation and differentiation – with a role also in memory, cognition and synaptic plasticity, can be implicated in the molecular mechanism of the aging process. Moreover, Heme Oxygenase-1a (HO), a 32 kDa heat-shock protein that converts heme to iron, carbon monoxide and biliverdin, is a key enzyme with neuroprotective properties. Several in vitro and in vivo studies reported that HO-1 could regulate the metabolism of oxysterols, oxidation products of cholesterol that include markers of oxidative stress. Recently, a link between Egr-1 and HO-1 has been demonstrated in mouse lung cells exposed to cigarette smoke. In view of these data, we wanted to investigate whether Egr-1 can be implicated also in the oxysterol metabolism during brain aging. Our results show that Egr-1 expression is differently expressed in the cortex and hippocampus of old mice, as well as the oxysterol profile between these two brain areas. In particular, we show that the cortex experiences in an age-dependent fashion increasing levels of the Egr-1 protein, and that these correlate with the level of HO-1 expression and oxysterol abundance. Such a situation was not observed in the hippocampus. These results are further strenghtened by our observations made with Egr-1 KO mice, confirming our hypothesis concerning the influence of Egr-1 on oxysterol production and accumulation via regulation of the expression of HO-1 in the cortex, but not the hippocampus, of old mice. It is important to notice that most of the oxysterols involved in this process are those usually stimulated by oxidative stress, which would then represent the triggering factor for this mechanism
Recommended from our members
Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
Specific protein misfolding and aggregation are mechanisms underlying various neurodegenerative diseases such as prion disease and Alzheimer's disease (AD). The misfolded proteins are involved in prions, amyloid-β (Aβ), tau, and α-synuclein disorders; they share common structural, biological, and biochemical characteristics, as well as similar mechanisms of aggregation and self-propagation. Pathological features of AD include the appearance of plaques consisting of deposition of protein Aβ and neurofibrillary tangles formed by the hyperphosphorylated tau protein. Although it is not clear how protein aggregation leads to AD, we are learning that the cellular prion protein (PrPC) plays an important role in the pathogenesis of AD. Herein, we first examined the pathogenesis of prion and AD with a focus on the contribution of PrPC to the development of AD. We analyzed the mechanisms that lead to the formation of a high affinity bond between Aβ oligomers (AβOs) and PrPC. Also, we studied the role of PrPC as an AβO receptor that initiates an AβO-induced signal cascade involving mGluR5, Fyn, Pyk2, and eEF2K linking Aβ and tau pathologies, resulting in the death of neurons in the central nervous system. Finally, we have described how the PrPC-AβOs interaction can be used as a new potential therapeutic target for the treatment of PrPC-dependent AD
Sex effect on presenilins expression in post-natal rat brain
Presenilin 1 and presenilin 2 are widely expressed during brain development. Several mutations in these proteins have been associated with autosomal-domi- nant inherited forms of Alzheimer disease. Their ex- pression is regulated by various cellular and ex- tracellular factors, which change with age and sex. Both age and sex are key risk factors for Alzheimer’s disease, but the issue of whether the expression of presenilins is influenced by the sex during early post- natal development of the brain has been poorly inves- tigated so far. In this study, we report that transcript levels of presenilins, and the subset of neurons ex- pressing these proteins in various brain areas of the developing post-natal brain are different in male and female rats, suggesting that their function(s) may contribute to sexual dimorphism in the brain, both at morphological and functional level
Heme oxygenase-1 and brain oxysterols metabolism are linked to Egr-1 expression in aged mice cortex, but not in hippocampus
Throughout life, stress stimuli act upon the brain leading to morphological and functional
changes in advanced age, when it is likely to develop neurodegenerative disorders.
There is an increasing need to unveil the molecular mechanisms underlying aging,
in a world where populations are getting older. Egr-1 (early growth response 1), a
transcriptional factor involved in cell survival, proliferation and differentiation – with a role
also in memory, cognition and synaptic plasticity, can be implicated in the molecular
mechanism of the aging process. Moreover, Heme Oxygenase-1a (HO), a 32 kDa
heat-shock protein that converts heme to iron, carbon monoxide and biliverdin, is a key
enzyme with neuroprotective properties. Several in vitro and in vivo studies reported that
HO-1 could regulate the metabolism of oxysterols, oxidation products of cholesterol that
include markers of oxidative stress. Recently, a link between Egr-1 and HO-1 has been
demonstrated in mouse lung cells exposed to cigarette smoke. In view of these data, we
wanted to investigate whether Egr-1 can be implicated also in the oxysterol metabolism
during brain aging. Our results show that Egr-1 expression is differently expressed in
the cortex and hippocampus of old mice, as well as the oxysterol profile between these
two brain areas. In particular, we show that the cortex experiences in an age-dependent
fashion increasing levels of the Egr-1 protein, and that these correlate with the level of
HO-1 expression and oxysterol abundance. Such a situation was not observed in the
hippocampus. These results are further strenghtened by our observations made with
Egr-1 KO mice, confirming our hypothesis concerning the influence of Egr-1 on oxysterol
production and accumulation via regulation of the expression of HO-1 in the cortex, but
not the hippocampus, of old mice. It is important to notice that most of the oxysterols
involved in this process are those usually stimulated by oxidative stress, which would
then represent the triggering factor for this mechanism
Thapsigargin affects presenilin-2 but not presenilin-1 regulation in SK-N-BE cells
Presenilin-1 (PS1) and presenilin-2 (PS2) are transmembrane proteins widely expressed in the central nervous system, which
function as the catalytic subunits of g-secretase, the enzyme that releases amyloid-b protein (Ab) from ectodomain cleaved
amyloid precursor protein (APP) by intramembrane proteolysis. Mutations in PS1, PS2, and Ab protein precursor are involved
in the etiology of familial Alzheimer’s disease (FAD), while the cause of the sporadic form of AD (SAD) is still not known. However,
since similar neuropathological changes have been observed in both FAD and SAD, a common pathway in the etiology of the
disease has been suggested. Given that age-related deranged Ca2þ regulation has been hypothesized to play a role in SAD
pathogenesis via PS gene regulation and g-secretase activity, we studied the in vitro regulation of PS1 and PS2 in the human
neuron-like SK-N-BE cell line treated with the specific endoplasmic reticulum (ER) calcium ATPase inhibitor Thapsigargin (THG), to
introduce intracellular Ca2þ perturbations and mimic the altered Ca2þ homeostasis observed in AD. Our results showed a consistent
and significant down-regulation of PS2, while PS1 appeared to be unmodulated. These events were accompanied by
oxidative stress and a number of morphological alterations suggestive of the induction of apoptotic machinery. The administration
of the antioxidant N-acetylcysteine (NAC) did not revert the THG-induced effects reported, while treatment with the Ca2þ-independent
ER stressor Brefeldin A did not modulate basal PS1 and PS2 expression. Collectively, these results suggest that Ca2þ
fluctuation rather than ER stress and/or oxidative imbalance seems to play an essential role in PS2 regulation and confirm that,
despite their strong homology, PS1 and PS2 could play different roles in AD
A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers
Sex is a significant variable in the prevalence and incidence of neurological disorders. Sex differences exist in neurodegenerative disorders (NDs), where sex dimorphisms play important roles in the development and progression of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. In the last few years, some sex specific biomarkers for the identification of NDs have been described and recent studies have suggested that microRNA (miRNA) could be included among these, as influenced by the hormonal and genetic background. Failing to consider the possible differences between males and females in miRNA evaluation could introduce a sex bias in studies by not considering some of these sex-related biomarkers. In this review, we recapitulate what is known about the sex-specific differences in peripheral miRNA levels in neurodegenerative diseases. Several studies have reported sex-linked disparities, and from the literature analysis miR-206 particularly has been shown to have a sex-specific involvement. Hopefully, in the near future, patient stratification will provide important additional clues in diagnosis, prognosis, and tailoring of the best therapeutic approaches for each patient. Sex-specific biomarkers, such as miRNAs, could represent a useful tool for characterizing subgroups of patients
M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition
Glioblastoma multiforme (GBM) is the most malignant brain tumor. Hypoxic condition
is a predominant feature of the GBM contributing to tumor growth and resistance to conventional
therapies. Hence, the identification of drugs able to impair GBM malignancy and aggressiveness
is considered of great clinical relevance. Previously, we demonstrated that the activation of M2
muscarinic receptors, through the agonist arecaidine propargyl ester (Ape), arrests cell proliferation
in GBM cancer stem cells (GSCs). In the present work, we have characterized the response of GSCs
to hypoxic condition showing an upregulation of hypoxia-inducible factors and factors involved
in the regulation of GSCs survival and proliferation. Ape treatment in hypoxic conditions is
however able to inhibit cell cycle progression, causing a significant increase of aberrant mitosis with
consequent decreased cell survival. Additionally, qRT-PCR analysis suggest that Ape downregulates
the expression of stemness markers and miR-210 levels, one of the main regulators of the responses
to hypoxic condition in dierent tumor types. Our data demonstrate that Ape impairs the GSCs
proliferation and survival also in hypoxic condition, negatively modulating the adaptive response of
GSCs to hypoxi